level

Comarch and F.I.L.A. S.p.A. strengthen the collaboration with the extension of electronic invoicing at the European level

MILAN, Oct. 7, 2025 /PRNewswire/ -- In continuity with the implementation in Italy in 2022, Comarch and F.I.L.A. S.p.A., a…

1 week ago

IOC announces comprehensive mental health support for athletes at Milano Cortina 2026

06 October 2025 - Athletes competing at the Milano Cortina 2026 Olympic Winter Games can expect the same high level of mental health…

1 week ago

HKUST Scientists Reveal Critical Impacts of a Chinese Genetic Risk Factor in Alzheimer’s Disease

HONG KONG, Oct. 2, 2025 /PRNewswire/ -- A landmark study conducted by The Hong Kong University of Science and Technology…

2 weeks ago

Next Level Aviation Appoints Danny Budding as Senior Vice President of Sales – Global

DANIA BEACH, Fla., Oct. 1, 2025 /PRNewswire/ -- Next Level Aviation® (NLA), a leader in the global distribution of used…

2 weeks ago

Ragp Balcolu Appointed as Beko’s Chief Marketing and Strategy Officer

Ragıp Balcıoğlu, who previously served as Chief Commercial Officer of Beko in the Europe region and the CEO of Beko…

2 weeks ago

Beko Europe Appoints Akn Garzanl as New CEO

Akın Garzanlı, who previously served as CMO of Beko has been appointed as the CEO of Beko Europe ISTANBUL, Oct.…

2 weeks ago

Beko scales Second-Life ‘Reduce-Refurbish-Recycle’ program to factory level across Europe

-  Beko extends product lifecycles, proving that circularity delivers both affordability and sustainability. -  In 2024, more than 114,000 appliances…

2 weeks ago

Kia Announces Pricing for 2026 Sorento PHEV

Numerous exterior design enhancementsTerrain Mode now standard on all AWD trims[1]2026 Kia Sorento PHEV MSRP starts at $48,290[2]Kia America has…

3 weeks ago

BYD improves Assisted Driving system in response to Euro NCAPs ATTO 3 grading

LEUVEN, BELGIUM – BYD has responded to the ’Not Recommended’ grading which Euro NCAP gave to the ATTO 3’s Assisted…

3 weeks ago

C4 Therapeutics Presents Cemsidomide Phase 1 Multiple Myeloma Data Supporting Potential Best-in-Class Profile at the International Myeloma Society Annual Meeting

September 20, 2025 11:00 ET  | Source: C4 Therapeutics, Inc. Cemsidomide in Combination With Dexamethasone Achieved a 50% Overall Response…

4 weeks ago